Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy.
Hepel JT, Leonard KL, Yashar CM, Einck JP, Sha SJ, DiPetrillo TA, Wiggins DL, Graves TA, Edmonson DA, Gass JS, Rivard MJ; Brown University Oncology Research Group; Wazer DE. Hepel JT, et al. Among authors: graves ta. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):878-883. doi: 10.1016/j.ijrobp.2023.12.026. Epub 2023 Dec 25. Int J Radiat Oncol Biol Phys. 2024. PMID: 38151190 Clinical Trial.
Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
Hepel JT, Leonard KL, Sha S, Graves TA, Wiggins DL, Mastras D, Pittier A; Brown University Oncology Research Group; Wazer DE. Hepel JT, et al. Among authors: graves ta. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1143-1149. doi: 10.1016/j.ijrobp.2020.07.2312. Epub 2020 Jul 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 32721422 Clinical Trial.
Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.
Hepel JT, Yashar C, Leonard KL, Einck JP, Sha S, DiPetrillo T, Wiggins D, Graves TA, Edmonson D; Brown University Oncology Research Group; Wazer DE. Hepel JT, et al. Among authors: graves ta. Brachytherapy. 2018 Sep-Oct;17(5):825-830. doi: 10.1016/j.brachy.2018.05.006. Epub 2018 Jun 21. Brachytherapy. 2018. PMID: 29936130 Clinical Trial.
Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study.
Sikov WM, Dizon DS, Strenger R, Legare RD, Theall KP, Graves TA, Gass JS, Kennedy TA, Fenton MA. Sikov WM, et al. Among authors: graves ta. J Clin Oncol. 2009 Oct 1;27(28):4693-700. doi: 10.1200/JCO.2008.21.4163. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720916 Clinical Trial.
78 results